Wilshire Technologies offers a product line of value-focused, non-cGMP and cGMP, largely phytochemically-derived products that include custom manufacturing through a worldwide network of long-term CMO partners and strategic sourcing alliances.
All of Wilshire Technologies production capacity is contracted. Most of the non-cGMP and phytochemical extraction/purification work is performed at China & India. Almost all cGMP production is performed in the USA. Management believes that in the existing global marketplace, this model offers more advantages than disadvantages for the production of fine chemicals — existing technological expertise, flexible production windows, varying production capacities — to cite but a few.
Many clients, even those with standing offices in China, recognize Wilshire Technologies’ extensive experience and deep networking within China — and India — and elect to purchase through WTI because it is a US company which imposes rigorous quality controls on its manufacturers, controls that many client are unable (or unwilling) to invest the effort to achieve.